Your browser doesn't support javascript.
loading
Safety and efficacy of first-line nivolumab plus ipilimumab alternating with nivolumab monotherapy in patients with advanced renal cell carcinoma: the non-randomised, open-label, phase IIIb/IV CheckMate 920 trial.
George, Daniel J; Spigel, David R; Gordan, Lucio N; Kochuparambil, Samith T; Molina, Ana M; Yorio, Jeff; Rezazadeh Kalebasty, Arash; McKean, Heidi; Tchekmedyian, Nishan; Tykodi, Scott S; Zhang, Joshua; Askelson, Margarita; Johansen, Jennifer L; Hutson, Thomas E.
Afiliação
  • George DJ; Division of Medical Oncology and Urology, Duke University School of Medicine, Durham, North Carolina, USA daniel.george@duke.edu.
  • Spigel DR; Lung Cancer Research Program, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, Tennessee, USA.
  • Gordan LN; Department of Hematology and Medical Oncology, Florida Cancer Specialists North/Sarah Cannon Research Institute, Gainesville, Florida, USA.
  • Kochuparambil ST; Department of Medical Oncology and Hematology, Minnesota Oncology, Minneapolis, Minnesota, USA.
  • Molina AM; Department of Medicine, Weill Cornell Medicine, New York City, New York, USA.
  • Yorio J; Department of Medical Oncology, Texas Oncology, Austin, Texas, USA.
  • Rezazadeh Kalebasty A; Department of Hematology and Medical Oncology, Norton Cancer Institute, Louisville, Kentucky, USA.
  • McKean H; Department of Hematology/Oncology, Avera, Sioux Falls, South Dakota, USA.
  • Tchekmedyian N; Pacific Shores Medical Group (Pacific Shores Medical Group is now part of City of Hope), Huntington Beach, California, USA.
  • Tykodi SS; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, Washington, USA.
  • Zhang J; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Askelson M; Department of Clinical Research, Bristol Myers Squibb, Princeton, New Jersey, USA.
  • Johansen JL; Department of Biostatistics, Bristol Myers Squibb, Princeton, New Jersey, USA.
  • Hutson TE; US Medical Immunology and Fibrosis, Bristol Myers Squibb, Princeton, New Jersey, USA.
BMJ Open ; 12(9): e058396, 2022 09 14.
Article em En | MEDLINE | ID: mdl-36104138
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Renais Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: BMJ Open Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Renais Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: BMJ Open Ano de publicação: 2022 Tipo de documento: Article